211 related articles for article (PubMed ID: 23873128)
21. Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.
Wei R; Cui X; Feng J; Gu L; Lang S; Wei T; Yang J; Liu J; Le Y; Wang H; Yang K; Hong T
Metabolism; 2020 Oct; 111():154324. PubMed ID: 32712220
[TBL] [Abstract][Full Text] [Related]
22. Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.
Willms B; Werner J; Holst JJ; Orskov C; Creutzfeldt W; Nauck MA
J Clin Endocrinol Metab; 1996 Jan; 81(1):327-32. PubMed ID: 8550773
[TBL] [Abstract][Full Text] [Related]
23. Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop.
Roberge JN; Brubaker PL
Endocrinology; 1993 Jul; 133(1):233-40. PubMed ID: 8319572
[TBL] [Abstract][Full Text] [Related]
24. Effects of Roux-en-Y gastric bypass and ileal transposition surgeries on glucose and lipid metabolism in skeletal muscle and liver.
Pezeshki A; Chelikani PK
Surg Obes Relat Dis; 2014; 10(2):217-28. PubMed ID: 24603111
[TBL] [Abstract][Full Text] [Related]
25. The corn protein, zein hydrolysate, administered into the ileum attenuates hyperglycemia via its dual action on glucagon-like peptide-1 secretion and dipeptidyl peptidase-IV activity in rats.
Mochida T; Hira T; Hara H
Endocrinology; 2010 Jul; 151(7):3095-104. PubMed ID: 20410194
[TBL] [Abstract][Full Text] [Related]
26. Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine.
Zhang Q; Xiao X; Li M; Li W; Yu M; Zhang H; Ping F; Wang Z; Zheng J
BMC Complement Altern Med; 2014 Jun; 14():188. PubMed ID: 24912407
[TBL] [Abstract][Full Text] [Related]
27. [Influences of exendin-4 on the secretion function of islet beta cells from rats in the early stage of severe scald].
Zhao DX; Ma L; Shen ZA; Li DW; Shang YR; Yin K; Cheng WF; Wang X; Liu ZX
Zhonghua Shao Shang Za Zhi; 2016 Dec; 32(12):752-758. PubMed ID: 28043300
[No Abstract] [Full Text] [Related]
28. The Effect of Gastric Bypass with a Distal Gastric Pouch on Glucose Tolerance and Diabetes Remission in Type 2 Diabetes Sprague-Dawley Rat Model.
Dolo PR; Shao Y; Li C; Zhu X; Yao L; Wang H
Obes Surg; 2019 Jun; 29(6):1889-1900. PubMed ID: 30778846
[TBL] [Abstract][Full Text] [Related]
29. Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model.
Patriti A; Facchiano E; Annetti C; Aisa MC; Galli F; Fanelli C; Donini A
Obes Surg; 2005 Oct; 15(9):1258-64. PubMed ID: 16259883
[TBL] [Abstract][Full Text] [Related]
30. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S
Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604
[TBL] [Abstract][Full Text] [Related]
31. Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1.
Rocca AS; LaGreca J; Kalitsky J; Brubaker PL
Endocrinology; 2001 Mar; 142(3):1148-55. PubMed ID: 11181530
[TBL] [Abstract][Full Text] [Related]
32. GIP and GLP-1(7-36)amide secretion in response to intraduodenal infusions of nutrients in pigs.
Knapper JM; Heath A; Fletcher JM; Morgan LM; Marks V
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Jul; 111(3):445-50. PubMed ID: 8564784
[TBL] [Abstract][Full Text] [Related]
33. The multifaceted potential of glucagon-like peptide-1 as a therapeutic agent.
Lam NT; Kieffer TJ
Minerva Endocrinol; 2002 Jun; 27(2):79-93. PubMed ID: 11961501
[TBL] [Abstract][Full Text] [Related]
34. Effects of ileal glucose infusion on enteropancreatic hormone secretion in humans: relationship to glucose absorption.
Zhang X; Cheng Z; Dong S; Rayner C; Wu T; Zhong M; Zhang G; Wang K; Hu S
Metabolism; 2022 Jun; 131():155198. PubMed ID: 35395220
[TBL] [Abstract][Full Text] [Related]
35. Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion.
Hansen M; Scheltema MJ; Sonne DP; Hansen JS; Sperling M; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
Diabetes Obes Metab; 2016 Jun; 18(6):571-80. PubMed ID: 26888164
[TBL] [Abstract][Full Text] [Related]
36. Ileal microbial shifts after Roux-en-Y gastric bypass orchestrate changes in glucose metabolism through modulation of bile acids and L-cell adaptation.
Dang JT; Mocanu V; Park H; Laffin M; Tran C; Hotte N; Karmali S; Birch DW; Madsen K
Sci Rep; 2021 Dec; 11(1):23813. PubMed ID: 34893681
[TBL] [Abstract][Full Text] [Related]
37. Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man.
Wettergren A; Petersen H; Orskov C; Christiansen J; Sheikh SP; Holst JJ
Scand J Gastroenterol; 1994 Jun; 29(6):501-5. PubMed ID: 7915853
[TBL] [Abstract][Full Text] [Related]
38. Glucagon-like peptide-1 (7-37) augments insulin-mediated glucose uptake in elderly patients with diabetes.
Meneilly GS; McIntosh CH; Pederson RA; Habener JF; Gingerich R; Egan JM; Elahi D
J Gerontol A Biol Sci Med Sci; 2001 Nov; 56(11):M681-5. PubMed ID: 11682575
[TBL] [Abstract][Full Text] [Related]
39. Glucagon-like peptide-1 plasmid construction and delivery for the treatment of type 2 diabetes.
Choi S; Oh S; Lee M; Kim SW
Mol Ther; 2005 Nov; 12(5):885-91. PubMed ID: 16039908
[TBL] [Abstract][Full Text] [Related]
40. Insulin sensitizers improve the GLP-1 secretion and the amount of intestinal L cells on high-fat-diet-induced catch-up growth.
Zheng J; Xiao KL; Chen L; Wu C; Hu X; Zeng T; Chen XQ; Li WJ; Deng X; Li H; Li YM
Nutrition; 2017; 39-40():82-91. PubMed ID: 28606576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
